Myriad Genetics Appoints Ben Wheeler Chief Financial Officer

Core Points - Myriad Genetics has promoted Ben Wheeler to Chief Financial Officer effective August 16, 2025, succeeding Scott Leffler who will transition to a consulting role [1][2][3] - Ben Wheeler has over 13 years of experience with Myriad, having held various leadership positions since joining in December 2011 [2] - The company reaffirms its financial guidance for the full-year 2025 as announced during its second quarter 2025 earnings call on August 5, 2025 [3] Company Overview - Myriad Genetics is a leader in molecular diagnostic testing and precision medicine, focusing on advancing health and well-being [4] - The company develops molecular tests that assess disease risk and guide treatment decisions, aiming to improve patient care and reduce healthcare costs [4]